Droxidopa in Treating Patients With Neurogenic Hypotension
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
Please note that the continuation study can be found at
http://clinicaltrials.gov/show/NCT00633880.
RATIONALE: Neurogenic hypotension is a fall in blood pressure that occurs when one moves from
a lying down to a standing position or after eating a meal. It causes one to feel dizzy,
light headed, and weak. Neurogenic hypotension is caused by a problem in the part of the
nervous system that controls such functions as heart rate and blood pressure. Droxidopa, a
drug that may increase blood pressure, may be an effective treatment for neurogenic
hypotension.
PURPOSE: Clinical trial to study the effectiveness of droxidopa in treating patients who have
neurogenic hypotension.